These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 37259170)

  • 1. Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications.
    Chen M; Jiang J; Hou J
    Biomark Res; 2023 May; 11(1):55. PubMed ID: 37259170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma.
    Bianchi G; Ghobrial IM
    Curr Cancer Ther Rev; 2014; 10(2):70-79. PubMed ID: 25705146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicine.
    Dutta AK; Alberge JB; Sklavenitis-Pistofidis R; Lightbody ED; Getz G; Ghobrial IM
    Nat Rev Clin Oncol; 2022 Apr; 19(4):223-236. PubMed ID: 35017721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Cell Sequencing in Genitourinary Malignancies.
    Murphy N; Shah P; Shih A; Khalili H; Liew A; Zhu X; Lee A
    Adv Exp Med Biol; 2020; 1255():153-164. PubMed ID: 32949398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of single-cell sequencing in cancer research: progress and perspectives.
    Lei Y; Tang R; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
    J Hematol Oncol; 2021 Jun; 14(1):91. PubMed ID: 34108022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review.
    Nishihori T; Shain K
    Int J Genomics; 2017; 2017():6934183. PubMed ID: 29250532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Insights into the Initiation, Evolution, and Progression of Multiple Myeloma by Multi-Omics Investigation.
    Gong L; Qiu L; Hao M
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Roles and Advantages of Single Cell Sequencing in the Diagnosis and Treatment of Hematological Malignancies.
    Shi M; Dong X; Huo L; Wei X; Wang F; Sun K
    Adv Exp Med Biol; 2018; 1068():119-133. PubMed ID: 29943300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in single-cell sequencing technology in the field of hepatocellular carcinoma.
    Qin R; Zhao H; He Q; Li F; Li Y; Zhao H
    Front Genet; 2022; 13():996890. PubMed ID: 36303541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric antigen receptor T-cell therapy for multiple myeloma.
    Wang Z; Chen C; Wang L; Jia Y; Qin Y
    Front Immunol; 2022; 13():1050522. PubMed ID: 36618390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
    Chung C
    Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Cell RNA Sequencing in Hematological Diseases.
    Zhu Y; Huang Y; Tan Y; Zhao W; Tian Q
    Proteomics; 2020 Jul; 20(13):e1900228. PubMed ID: 32181578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell profiling in multiple myeloma: insights, problems, and promises.
    Samur MK; Szalat R; Munshi NC
    Blood; 2023 Jul; 142(4):313-324. PubMed ID: 37196627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathology and treatment of multiple myeloma understood from the tumor cell-of-origin perspective].
    Tanaka H
    Rinsho Ketsueki; 2020; 61(9):1317-1324. PubMed ID: 33162531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Single-Cell Multi-Omics in Dissecting Cancer Cell Plasticity and Tumor Heterogeneity.
    Pan D; Jia D
    Front Mol Biosci; 2021; 8():757024. PubMed ID: 34722635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor heterogeneity of acute myeloid leukemia: insights from single-cell sequencing.
    Chen A; Hu S; Wang QF
    Blood Sci; 2019 Aug; 1(1):73-76. PubMed ID: 35402804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis beyond the cancer clone(s) in multiple myeloma.
    Bianchi G; Munshi NC
    Blood; 2015 May; 125(20):3049-58. PubMed ID: 25838343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell sequencing and its applications in bladder cancer.
    Wei W; Rong Y; Sanhe L; Chunxiu Y; Thokerunga E; Cui D; Wang F
    Expert Rev Mol Med; 2022 Jan; 24():e6. PubMed ID: 35086606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic single-cell RNA-seq analysis reveals distinct tumor program associated with microenvironmental remodeling and drug sensitivity in multiple myeloma.
    Chen M; Wan Y; Li X; Xiang J; Chen X; Jiang J; Han X; Zhong L; Xiao F; Liu J; Huang H; Li H; Liu J; Hou J
    Cell Biosci; 2023 Jan; 13(1):19. PubMed ID: 36717896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncoding RNAs in the crosstalk between multiple myeloma cells and bone marrow microenvironment.
    Tang W; Xu J; Xu C
    Cancer Lett; 2023 Mar; 556():216081. PubMed ID: 36739065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.